Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134726) titled 'A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of IL-1 Inhibitor in the Treatment of Refractory Bechet's Disease' on Oct. 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shandong Provincial Hospital

Condition: Bechet's Disease

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-11-01

Target Sample Size: Firsekibart Group:33;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=343657

Disclaimer: Curated by HT Syndication....